Abstract
Urticaria and angioedema are common disorders affecting approximately 15-20% of the population at least once during their lifetime (Swinny, 1941; Sheldon et al., 1954; McKee, 1966). Urticarial lesions result from localized dilatation and transudation of fluid from small venules, and in their simplest form are thought to represent the same sort of wheal-and-flare reaction observed when histamine is injected into the skin. Clinically, one observes the presence of pruritic, erythematous cutaneous wheals that blanch with pressure, reflecting the underlying edema and dilated blood vessels. The histopathological features of urticaria are dilatation of cutaneous blood vessels and lymphatics in the superficial dermis, widening of dermal papillae, flattening of rete pegs, and swelling of collagen fibers.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Alper, C. A., Rosen, F. S., and Lachmann, P. J., 1972, Inactivator of the third component of complement as an inhibitor of the properdin pathway, Proc. Natl. Acad. Sci. USA 69: 2910–2913.
Anderson, V., Buch, N. H., Jensen, M. K., and Killmann, S., 1967, Deafness, urticaria, and amyloidosis: A sporatic case with chromosomal aberration, Am. J. Med. 42: 449–456.
Aoyama, H., Katsumata, Y., and Olzawa, T., 1970, Dermographism-inducing principle of urticaria factitia, Jpn. J. Dermatol. 80: 122.
Arbesman, C. E., and Reisman, R. E., 1971, Serum sickness and human anaphylaxis, in: Immunologic Diseases, Vol. I ( M. Samter, ed.), p. 495, Little, Brown, Boston.
Austen, K. F., and Sheffer, A. L., 1965, Detection of hereditary angioneurotic edema by demonstration of a reduction in the second component of human complement, N. Engl. J. Med. 272: 649–656.
Baer, R. L., and Hauber, L. C., 1971, Reactions to light, heat, and trauma, in: Immunological Diseases ( M. Samter, ed.), p. 973, Little, Brown, Boston.
Ballow, M., Ward, G. W., Jr., Gershwin, M. E., and Day, N. K., 1975, Cl bypass complementactivation pathway in patients with chronic urticaria and angioedema, Lancet 2:248–250. Beall, G. N., 1964, Urticaria: A review of laboratory and clinical observations, Medicine 43: 131–151.
Bentley-Phillips, C. B., Black, A. K., and Greaves, M. W., 1976, Induced tolerance in cold urticaria caused by cold-evoked histamine release, Lancet 2: 63–66.
Benveniste, J., Henson, P. M., and Cochrane, C. G., 1972, Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet activating factor, J. Exp. Med. 136: 1356–1377.
Benveniste, J., Kamoun, P., and Polonsky, J., 1975, Aggregation of human platelets by purified platelet activating factor from human and rabbit basophils, Fed. Proc. 34: 985 (abstr.).
Black, J. T., 1969, Amyloidosis, deafness, urticaria, and limb pains: A hereditary syndrome, Ann. Intern. Med. 70: 989–994.
Bokisch, V. A., Müller-Eberhard, H. J., and Cochrane, C. G., 1969, Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human plasma, J. Exp. Med. 129: 1109–1130.
Boswell, R. N., Austen, K. F., and Goetzl. E. J., 1978, Intermediate molecular weight eosinophil chemotactic factors in rat peritoneal mast cells: Immunologic release, granule association, and demonstration of structural heterogeneity, J. Immunol. 120: 15–20.
Braverman, I. M., 1967, Urticaria as a sign of internal disease, Postgrad. Med. 41: 450–454.
Braverman, I. M., and Yen, A., 1975, Demonstration of immune complexes in spontaneous and histamine-induced lesions and normal skin of patients with leucocytoclastic angiitis, J. Invest. Dermatol. 64: 105–112.
Caldwell, J. R., Ruddy, S., Schur, P., and Austen, K. F., 1972, Acquired Cl inhibitor deficiency in lymphosarcoma, Clin. Immunol. Immunopathol 1: 39–52.
Carpenter, C. B., Ruddy, S., Shehadeh, I. H., Muller-Eberhard, H. J., Merrill, J. P., and Austen, K. F., 1969, Complement metabolism in man: Hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary angioedema, J. Clin. Invest. 48: 1495–1505.
Chalamidas, S. L., and Charles, C. R., 1971, Aquagenic urticaria, Arch. Dermatol. 104: 541–546.
Champion, R. H., Roberts, S. O. B., Carpenter, R. G., and Roger, J. H., 1969, Urticaria and angioedema, Br. J. Dermatol. 81: 588–597.
Chester, A., Liebowitz, H., and Marklow, H., 1959, Causes of chronic urticaria including infection, N. Y. State J. Med. 59: 1786.
Clark, R. A. F Gallin, J. I., and Kaplan, A. P., 1975, The selective eosinophilic chemotactic activity of histamine, J. Exp. Med. 142: 1462–1476.
Clark, R. A. F., Gallin, J. I., and Kaplan, A. P., 1976, Mediator release from basophil granulocytes in chronic myelogenous leukemia: Demonstration of the eosinophil chemotactic activity of histamine, J. Allergy Clin. Immunol. 58: 623–634.
Clark, R. A. F., Sandler, J. A., Gallin, J. I., and Kaplan, A. P., 1977, Histamine modulation of eosinophil migration, J. Immunol. 118: 137–145.
Cochrane, C. G., and Müller-Eberhard, H. J., 1968, The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement, J. Exp. Med. 127: 371–386.
Cochrane, C. G., Revak, S. D., Aiken, B. S., and Wuepper, K. D., 1972, The structural characteristics and activation of Hageman factor, in: Inflammation: Mechanism and Control ( I. Lepow and P. Ward, eds.), pp. 119–129, Academic, New York.
Cochrane, C. G., Revak, S. D., and Wuepper, K. D., 1973, Activation of Hageman factor in solid and fluid phases: A critical role of kallikrein, J. Exp. Med. 138: 1564–1583.
Colman, R. W., Bagdasarian, A., Talamo, R. C., Scott, C. F., Seavey, M., Guimaraes, J. A., Pierce, J. V., and Kaplan, A. P., 1975, Williams trait: Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor dependent pathways, J. Clin. Invest. 56: 1650–1662.
Copeman, P. W. M., and Ryan, J. J., 1970, The problems of classification of cutaneous angiitis with reference to histopathology and pathogenesis, Br. J. Dermatol. 82 (5): 2.
Costanzi, J. J., and Coltman, J. C., Jr., 1967, Kappa chain precipitable immunoglobulin G (IgG) associated with cold urticaria. I. Clinical observations, Clin. Exp. Immunol. 2: 167–178.
Costanzi, J. J., Coltman, C. A., Jr., and Donaldson, V. H., 1969, Activation of complement by a monoclonal cryoglobulin associated with cold urticaria, J. Lab. Clin. Med. 74: 902–910.
Cowdry, S. C., and Reynolds, J. S., 1969, Acute urticaria in infectious mononucleosis, Ann. Allergy 27: 182–187.
Daha, M. R., Fearon, D. T., and Austen, K. F., 1976a, C3 nephritic factor (C3 Nef): Stabilization of fluid phase and cell bound alternative pathway convertase, J. Immunol. 116: 1–7.
Daha, M. R., Fearon, D. T., and Austen, K. F., 1976b, Isolation of alternative pathway C3 convertase containing uncleaved B and formed in the presence of C3 nephritic factor (C3 Nef), J. Immunol. 116: 568–570.
Davis, A. E., Arnaout, M. A., Alper, C. A., and Rosen, F. S., 1977, Transfer of C3 nephritic factor from mother to fetus: Is C3 nephritic factor IgG, N. Engl. J. Med. 297: 144–146.
Davis, P. J., Davis, F. B., and Charache, P., 1974, Long term therapy of hereditary angioedema (HAE): Preventive management with fluoxymesterone and oxymetholone in severely affected males and females, Johns Hopkins Med. J. 135: 391–398.
DeWeck, A. L., 1971, Immunological effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations, Int. Arch. Allergy Appl. Immunol. 41: 393–418.
Dolovich, J., Hargreave, F. E., Chalmers, R., Shier, K. J., Gauldie, J., and Bienenstock, J., 1973, Late cutaneous allergic responses on isolated IgE-dependent reactions, J. Allergy Clin. Immunol. 52: 38–46.
Donaldson, V. H., 1968, Mechanisms of activation of Cl esterase in hereditary angioneurotic edema plasma in vitro: The role of Hageman factor, a clot-promoting agent, J. Exp. Med. 127: 411–429.
Donaldson, V. H., and Evans, R. R., 1963, A biochemical abnormality in hereditary angioneurotic edema, Am. J. Med. 35: 37–44.
Donaldson, V. H., and Rosen, F. S., 1966, Hereditary angioneurotic edema: A clinical survey, Pediatrics 37: 1017–1027.
Donaldson, V. H., Ratnoff, O. D., DaSilva, W. D., and Rosen, F. S., 1969, Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization, J. Clin. Invest. 48: 642–653.
Douglas, H. M. G., and Bleumink, E., 1974, Familial cold urticaria. Arch. Dermatol. 110:382–388. Eisen, V., and Loveday, C., 1972, Activation of arginine and tyrosine esterase in serum from patients with hereditary angioedema, Br. J. Pharm. 46: 157–166.
Farah, F. S., and Shbaklu, Z., 1971, Autoimmune progesterone urticaria, J. Allergy Clin. Immunol. 48: 257–261.
Fearon, D. T., and Austen, K. F., 1975a, Initiation of C3 cleavage in the alternative complement pathway, J. Immunol. 115: 1357–1361.
Fearon, D. T., and Austen, K. F., 1975b, Properdin: Initiation of alternative complement pathway, Proc. Natl. Acad. Sci. USA 72: 3220–3224.
Fearon, D. T., and Austen, K. F., 1975c, Properdin: Binding to C3b and stabilization of the C3bdependent C3 convertase, J. Exp. Med. 142: 856–863.
Fearon, D. T., Austen, K. F., and Ruddy, S., 1974, Properdin factor D: Characterization of its active site and isolation of the precursor form, J. Exp. Med. 139: 355–366.
Fernandez, H. N., Henson, P. M., Otani, A., and Hugh, T. E., 1978, Chemotactic response to human C3a and C5a anaphylatoxins. I. Evalution of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions, J. Immunol. 120: 109.
Frank, M. M., Sergent, J. S., Kane, M. A., and Ailing, D. W., 1972, Epsilon aminocaproic and therapy of hereditary angioneurotic edema: A double blind study, New Engl. J. Med. 286: 808–812.
Gallin, J. I., and Kaplan, A. P., 1974, Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by Cl INH and alpha-2 macroglobulin, J. Immunol. 113: 1928–1934.
Gelfand, J. A., Sherins, R. J., Alling, D. W., and Frank, M. M„ 1976, Treatment of hereditary angioedema with danazol: Reversal of clinical and biochemical abnormalities, N. Engl. J. Med. 275: 1444–1448.
Gewerz, H., Shin, H. S., and Mergenhagen, S. E., 1968, Interactions of the complement system with endotoxic lipopolysaccharide: Consumption of each of the six terminal complement components, J. Exp. Med. 128: 1049–1057.
Gigli, I., Mason, J. W., Colman, R. W., and Austen, K. F., 1970, Interaction of plasma kallikrein with the Cl inhibitor, J. Immunol. 104: 574–581.
Goetzl, E. J., and Austen, K. F., 1975, Purification and synthesis of eosinophil tetrapeptides of human lung tissue: Identification as eosinophil chemotactic factor of anaphylaxis, Proc. Natl. Acad. Sci. USA 72: 4123–4127.
Goetzl, E. J., Wasserman, S. I., and Austen, K. F., 1974, Modulation of the eosinophil chemotactic response in immediate hypersensitivity, in: Progress in Immunology II, Vol. 4 ( L. Brent and J. Holborow, eds.), pp. 41–50, North-Holland, Amsterdam.
Golbert, T. M., Patterson, R., and Pruzansky, J. J., 1969, Systemic allergic reactions to ingested antigens, J. Allergy 44: 96.
Götze, O., and Müller-Eberhard, H. J., 1971, The C3-activator system: An alternative pathway of complement activation, J. Exp. Med. 134: 905.
Götze, O., and Müller-Eberhard, H. J., 1974, The role of properdin in the alternate pathway of complement activation, J. Exp. Med. 139: 44–57.
Grant, J. A., Dupree, E., Goldman, A. S., Schultz, D. R., and Jackson, A. L., 1975
Complementmediated release of histamine from human leukocytes, J. Immunol. 114:1101–1106.
Grant, R. T., Pearson, R. S. B., and Corneau, W. J., 1935, Observations on urticaria provoked by emotion, by exercise and by warming the body, Clin. Sci. 2: 253–272.
Greaves, M. W., and Sondergaard, J., 1970, Urticaria pigmentosa and factitious urticaria: Direct evidence for release of histamine and other smooth muscle-contracting agents in dermographic skin, Arch. Dermatol. 101: 418–425.
Griffin, J. H., and Cochrane, C. G., 1976, Mechanisms for the involvement of high molecular weight kininogen in surface-dependent reactions of Hageman factor, Proc. Natl. Acad. Sci. USA 73: 2554–2558.
Griffin, J. H., Harper, E., and Cochrane, C. G., 1975, Studies on the activation of human blood coagulation factor XII (Hageman factor) by soluble collagen, Fed. Proc. 34: 860.
Harber, L. C., Holloway, R. M., Sheatley, V. R., and Baer, R. L., 1963, Immunologic and biophysical studies in solar urticaria, J. Invest. Dermatol. 41: 439–443.
Hathaway, W. E., and Alsever, J., 1970, The relation of “Fletcher factor” to factors XI and XII, Br. J. Haematol. 18: 161–169.
Hathaway, W. E., Belhausen, L. P., and Hathaway, H. S., 1965, Evidence of a new plasma thromboplastin factor, I. Case report, coagulation studies and physicochemical properties, Br. J. Haematol. 26: 521–532.
Herxheimer, A., 1956, The nervous pathway mediating cholinergic urticaria, Clin. Sci. 15: 195–204.
Horton, B. T., Brown, G. E., and Roth, G. M., 1936, Hypersensitivities to cold with local and systemic manifestations of a histamine-like character: Its amenability to treatment, J. Am. Med. Assoc. 107: 1263–1269.
Houser, D. D., Arbesman, C. E., Ito, K., and Wicher, K., 1970, Cold urticaria: Immunologic studies, Am. J. Med. 49: 23–33.
Isaacs, N. J., and Ertel, N. H., 1971, Urticaria and pruritis: Uncommon manifestations of hyperthyroidism, J. Allergy Clin. Immunol. 48: 73–81.
Ishizaka, K., DeBernardo, R., Tomioka, H., Lichtenstein, L., and Ishizaka, T., 1972, Identification of basophil granulocytes as a site of allergic histamine release, J. Immunol. 108: 1000–1008.
Johnson, A. M., Alper, C. A., Rosen, F. S., and Crain, J. M., 1971, Cl inhibitor: Evidence for decreased hepatic synthesis in hereditary angioneurotic edema, Science 173: 553–554.
Juhlin, L., and Michaelsson, G., 1969, Vascular reactions in hereditary angioedema, Acta Derm. Venereol. 49: 20–25.
Juhlin, L., Michaelsson, G., and Zetterstrom, O., 1972, Urticaria and asthma induced by food and drug additives in patients with aspirin sensitivity, J. Allergy Clin. Immunol. 50: 92–98.
Kaplan, A. P., 1977, Mediators of urticaria and angioedema, J. Allergy Clin. Immunol. 60: 324–332.
Kaplan, A. P., and Austen, K. F., 1970, A prealbumin activator of prekallikrein, J. Immunol. 105: 802–811.
Kaplan, A. P., and Austen, K. F., 1971, A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin, J. Exp. Med. 133: 696–712.
Kaplan, A. P., and Austen, K. F., 1972, The fibrinolytic pathway of human plasma: Isolation and characterization of the plasminogen proactivator, J. Exp. Med. 136: 1378–1393.
Kaplan, A. P., and Beaven, M. A., 1976, In vivo studies of the pathogenesis of cold urticaria, cholinergic urticaria, and vibration-induced swelling, J. Invest. Dermatol. 67: 327–332.
Kaplan, A. P., Kay, A. B., and Austen, K. F., 1972, A prealbumin activator of prekallikrein. III. Appearance of chemotactic activity for human neutrophile by the conversion of human prekallikrein to kallikrein, J. Exp. Med. 135: 81–97.
Kaplan, A. P., Goetzl, E. J., and Austen, K. F., 1973, The fibrinolytic pathway of human plasma. II. Generation of chemotactic activity by activation of plasminogen proactivator, J. Clin. Invest. 52: 2591–2597.
Kaplan, A. P., Meier, H. L., Yecies, L. D., and Heck, L. W., 1974, Hageman factor and its substrates: The role of factor XI (PTA), prekallikrein, and plasminogen proactivator in coagulation, fibrinolysis, and kiningeneration, in: The Kallikrein System in Health and Disease: Fogarty International Center Proceedings, No. 27 (J. I., Pisano and K. F. Austen, ed.), pp. 237–254, U.S. Government Printing Office, Washington, D.C.
Kaplan, A. P., Gray, L., Shaff, R. E., Horakova, Z., and Beaven, M. A., 1975, In vivo studies of mediator release in cold urticaria and cholinergic urticaria, J. Allergy Clin. Immunol. 55: 394–402.
Kaplan, A. P., Horakova, Z., and Katz, S. I., 1978, Assessment of tissue fluid histamine levels in patients with urticaria, J. Allergy Clin. Immunol. 61: 350–354.
Kater, L. A., Austen, K. F., and Goetzl, E. J., 1975, Identification and partial purification of a platelet activating factor (PAF) from rat, Fed. Proc. 34: 985 (abstr.).
Kay, A. B., and Austen, K. F., 1971, The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung, J. Immunol. 107: 889–02.
Kay, A. B., Stechschulte, D. J., and Austen, K. F., 1971, An eosinophil leukocyte chemotactic factor of anaphylaxis, J. Exp. Med. 133: 602–619.
Kellermeyer, R. W., and Breckenridge, R. T., 1965, The inflammatory process in acute gouty arthritis. I. Activation of Hageman factor by sodium urate crystals, J. Lab. Clin. Med. 65: 307–315.
Kennedy, D. D., Rosenthal, F. D., and Sneddon, I. B., 1966, Amyloidosis presenting as urticaria, Br. Med. J. 1: 31–32.
Kern, F., and Lichtenstein, L. M., 1976, Defective histamine release in chronic urticaria, J. Clin. Invest. 57: 1369–1377.
Klemperer, M. R., Donaldson, V. H., and Rosen, F. S., 1968, The vasopermeability response in man to purified Cl esterase, J. Clin. Invest. 47: 604 (abstr.).
Koehn, G. G., and Thorne, E. G., 1972, Urticaria and viral hepatitis, Arch. Dermatol. 106: 422.
Kohler, P. F., 1973, Clinical immune complex disease: Manifestations in systemic lupus erythematosus and hepatitis B virus infection, Medicine 52: 419–429.
Lever, W. F., and Schaumburg-Lever, G., 1975, Histopathology of the Skin, p. 133, Lippincott, Philadelphia. Levine, B. B., 1966, Immunochemical mechanisms of penicillin allergy, N. Engl. J. Med. 275: 1115–1125.
Levine, M. I., 1975, Chronic urticaria, J. Allergy Clin. Immunol. 55: 276–283.
Lewis, T., 1927, The Blood Vessels of the Human Skin and Their Responses,Shaw and Sons, London. Ljunggren, B., and Moller, H., 1971, Hepatitis presenting as transient urticaria, Acta Derm. Venereol. 51: 295–297.
Lockey, S. D., 1971, Reactions to hidden agents in foods, beverages, and drugs, Ann. Allergy 29: 461–466.
Lockshin, N. A., and Hurley, H., 1972, Urticaria as a sign of viral hepatitis, Arch. Dermatol. 105: 570–571.
Lundh, B., Laurell, A., Wetterqvist, H., White, T., and Granerus, G., 1968, A case of hereditary angioneurotic edema successfully treated with eaminocaproic acid, Clin. Exp. Immunol. 3: 733–745.
Mandle Jr., R. J., and Kaplan, A. P., 1977, Hageman factor substrates. II. Human plasma prekallikrein. Mechanism of activation by Hageman factor and participation in Hageman factor dependent fibrinolysis, J. Biol. Chem. 252: 6097–6104.
Mandle, R. J., Jr., Colman, R. W., and Kaplan, A. P., 1976, Identification of prekallikrein and HMW kininogen as a circulating complex in human plasma, Proc. Natl. Acad. Sci. USA 73: 4179.
Marder, R. J., Rent, R., and Enoi, E. Y. C., 1976, Clq deficiency associated with urticarial-like lesions and cutaneous vasculitis, Am. J. Med. 61: 560–565.
Mathison, D. A., Arroyave, L. M., Bhat, K. N., Hurewitz, D. S., and Marnell, D. J., 1977, Hypocomplementemia in chronic urticaria, Ann. Intern. Med. 86: 534–538.
McDuffie, F. C., Sams Jr., W. M., Maldonado, J. E., Andreini, P. H., Conn, D. L., and Samayoa, E. A., 1973, Hypocomplementemia with cutaneous vasculitis and arthritis, Mayo Clin. Proc. 48: 340.
McKee, W. D., 1966, The incidence and familial occurrence of allergy, J. Allergy 38: 226–235.
McMillan, C. R., Saito, H., Ratnoff, O. D., and Walton, A. D., 1974, The secondary structure of human Hageman factor (factor XII), J. Clin. Invest. 54: 1312–1322.
Meier, H. L., Pierce, J. V„ Colman, R. W., and Kaplan, A. P., 1977, Activation and function of human Hageman factor: The role of high molecular weight kininogen and prekallikrein, J. Clin. Invest. 60: 18–31.
Metzger, W. J., Kaplan, A. P., Beaven, M. A., Irons, J., and Patterson, R., 1976, Hereditary vibratory angioedema: Confirmation of histamine release in a type of physical hypersensitivity, J. Allergy Clin. Immunol. 57: 605–608.
Michaelsson, G., and Juhlin, L., 1973, Urticaria induced by preservatives and dye additives in food and drugs, Br. J. Dermatol. 88: 525–532.
Moore-Robinson, M., and Warin, K. P., 1908, Some clinical aspects of cholinergic urticaria, Br. J. Dermatol. 80: 794–799.
Moroz, L. A., and Rose, B., 1971, The cryopathies, in: Immunological Diseases ( M. Samter, ed.), p. 459, Little, Brown, Boston.
Morrison, D. C., and Cochrane, C. G., 1974, Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins), J. Exp. Med. 140: 787–811.
Moshell, A. N., and Bjornson, L., 1977, Photoprotection in erythropoietic protoporphyria: Mechanism of protection by beta carotene, J. Invest. Dermatol. 68: 157–160.
Moskowitz, A. N., Schwartz, H. J., Michel, B., Ratnoff, O. D., and Astrup, T., 1970, Generation of kinin-like agents by chondroitin sulfate, heparin, chitin sulfate, and human articular cartilage: Possible pathophysiologic implications, J. Lab. Clin. Med. 76: 790–798.
Muckle, T. J., and Wells, M., 1962, Urticaria, deafness, and amyloidosis: A new heredo-familial syndrome, Q. J. Med. 31: 235–248.
Müller-Eberhard, H. J., and Gotze, O., C3 proactivator convertase and its mode of action, J. Exp. Med. 135: 1003–1008.
Müller-Eberhard, H. J., Polley, M. J., and Calcott, M. A., 1967, Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement, J. Exp. Med. 125: 359–380.
Naff, G. B., Pensky, J., and Lepow, I. H., 1964, The macromolecular nature of the first component of human complement, J. Exp. Med. 119: 593–613.
Newcomb, R. W., and Nelson, H„ 1973, Dermographia mediated by immunoglobulin E, Am. J. Med. 54: 174–180.
Niewiarowski, S., Bankowski, E., and Rogowicka, I., 1965, Studies on the adsorption and activation of the Hageman factor (factor XII) by collagen and elastin, Thromb. Diath. Haemorr. 14: 387–400.
Noid, H. E., Schulze, T. W., and Winkelman, R. K., 1974, Diet plan for patients with salicylate-induced urticaria, Arch. Dermatol. 109: 886–889.
Orange, R. P., and Austen, K. F., 1972, Immunologic and pharmacologic receptor control of the release of chemical mediators from human lung, in: The Biological Role of the Immunoglobulin E System ( K. Ishizaka and D. H. Dayton, Jr., eds.), p. 151, National Institutes of Health, Bethesda, Md.
Orange, R. P., Murphy, R. C., Karnovsky, M. L., and Austen, K. F., 1973, The physicochemical characteristics and purification of slow reacting substance of anaphylaxis, J. Immunol. 110: 760–770.
Orfunos, C. E., Schaumburg-Lever, G., and Lever, W. F., 1974, Dermal and epidermal types of erythema multiforme, Arch. Dermatol. 109: 682–688.
Patterson, R., Mellies, C. J., Blankenship, M. L., and Pruzansky, J. J., 1972, Vibratory angioedema: A hereditary type of physical hypersensitivity, J. Allergy Clin. Immunol. 50: 174–182.
Paver, W. K., 1971, Discoid and subacute systemic lupus erythematosus associated with urticaria, Aust. J. Dermatol. 12: 113.
Pearson, K. D., Buchignani, J. S., Shimkin, P. M., and Frank, M. M., 1972, Hereditary angioneurotic edema of the gastrointestinal tract, Am. J. Roentgenol. Radium Ther. Nucl. Med. 116: 256–261.
Pillemer, L., Blum, L., Lepow, I. H., Ross, O. A., Todd, E. W., and Wardlaw, A. C., 1954, The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena, Science 120: 279–285.
Ratnoff, O. D., and Naff, G. B., 1967, The conversion of C’ 1S to C’1 esterase by plasmin and trypsin, J. Exp. Med. 125: 337–358.
Ratnoff, O. D., Davie, E. W., and Mallet, D. L., 1961, Studies on the action of Hageman factor: Evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent, J. Clin. Invest. 10: 803–819.
Rocklin, R. E., and David, J. R., 1971, Detection of in vitro cellular hypersensitivity to drugs, J. Allergy Clin. Immunol. 48: 276–282.
Rorsman, H., 1962, Studies on basophil leukocytes with special reference to urticaria and anaphylaxis, Acta Derm. Venereol. 42:1–20 (Suppl. 48 ).
Rosen, F. S., Alper, C. A., Pensky, J., Klemperer, M. R., and Donaldson, V. H., 1971, Genetic heterogeneity of the Cl esterase inhibitor in patients with hereditary angioneurotic edema, J. Clin. Invest. 50: 2143–2149.
Rosse, W. F., Logue, G. L., and Silberman, H. R., 1976, The effect of synthetic androgens on the clinical course and Cl esterase (Ci INH) levels in hereditary angioneurotic edema (HANE), Clin. Res. 24: 428A.
Roth, G. J., Stanford, N., and Majerus, P. W., 1975, Acetylation of prostaglandin synthase by aspirin, Proc. Natl. Acad. Sci. USA 72: 3073–3076.
Ruddy, S., Gigli, I., Sheffer, A. L., and Austen, K. F., 1968, The laboratory diagnosis of hereditary angioedema, in: Allergology, Proceedings of the Sixth International Congress of Allergology (Rose, Richter, Sehon, and Frankland, eds.), pp. 351–359, Excerpta Medica, Amsterdam.
Sams, W. M., Jr., Epstein, J. H., and Winkelmann, R. K., 1969, Solar urticaria: Investigation of pathogenic mechanisms, Arch. Dermatol. 99: 390–397.
Samter, M., and Beers, Jr., R. F., 1967, Concerning the nature of intolerance to aspirin, J. Allergy 40: 281–293.
Schreiber, A. D., Kaplan, A. P., and Austen, K. F., 1973, Inhibition by CI INH of Hageman factor fragment activation of coagulation, fibrinolysis, and kinin generation, J. Clin. Invest. 52: 1402–1409.
Schreiber, R. D., Medicus, R. G., Gotze, O., and Müller-Eberhard, H. J., 1975, Properdin and nephritic factor-dependent C3 convertases: Requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor, J. Exp. Med. 142: 760–772.
Settipane, G. A., and Pudupakkam, R. K., 1975, Aspirin intolerance. III. Subtypes, familial occurrence, and cross-reactivity with tartrazine, J. Allergy Clin. Immunol. 56: 215–221.
Settipane, G. A., Chafee, F. H., Postman, I. M., Levine, M. I., Saker, J. H., Barrick, R. H., Nicholas, S. S., Schwartz, M. D., Honsinger, R. N., and Klein, D. E., 1975, Significance of tartrazine sensitivity in chronic urticaria of unknown etiology, J. Allergy Clin. Immunol. 57: 541–546.
Sheffer, A. L., Craig, J. M., Willms-Kretschmer, K., Austen, K. F., and Rosen, F. S., 1971, Histopathological and ultrastructural observations on tissues from patients with hereditary angioneurotic edema, J. Allergy 47: 292–297.
Sheffer, A. L., Austen, K. F., and Rosen, F. S., 1972, Tranexamic acid therapy in hereditary angioneurotic edema, N. Engl. J. Med. 287: 452–454.
Sheldon, J. M., Mathews, K. P., and Lovell, R. G., 1954, The vexing urticaria problem: Present concepts of etiology and management, J. Allergy 25: 525–560.
Sheldon, J. M., Lovell, R. G., and Mathews, K. P., 1967, A Manual of Clinical Allergy, 2nd ed. p. 196, Saunders, Philadelphia.
Shelley, W. B., 1969, Urticaria of nine years duration cleared following dental extraction, Arch. Dermatol. 100: 324–325.
Sissons, J. G. F., Williams, D. G., Peters, D. K., and Boulton-Jones, J. M., 1974, Skin lesions, angioedema, and hypocomplementemia, Lancet (Dec.) 7: 1350–1352.
Soter, N. A., Austen, K. F., and Gigli, I., 1974a, The complement system in necrotizing angiitis of the skin: Analysis of complement component activities in serum of patients with concomitant collagen-vascular diseases, J. Invest. Dermatol. 63: 219–226.
Soter, N. A., Austen, K. F., and Gigli, I., 1974b, Urticaria and arthralgias as manifestation of necrotizing angiitis, J. Invest. Dermatol. 63: 485–490.
Soter, N. A., Austen, K. F., and Gigli, I., 1975, Inhibition by e-aminocaproic acid of the activation of the first component of the complement system, J. Immunol. 114: 928–932.
Soter, N. A., Mihm Jr., M. C., Gigli, I., Dvorak, H. F., and Austen, K. F., 1976a, Two distinct cellular patterns in cutaneous necrotizing angiitis, J. Invest. Dermatol. 66: 334–350.
Soter, N. A., Wasserman, S. I., and Austen, K. F., 1976b, Cold urticaria: Release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge, N. Engl. J. Med. 294: 687–690.
Soter, N. A., Joshi, N. P., Twarog, F. J., Zeiger, R. S., Rothman, P M, and Colton, H. R., 1977, Delayed cold-induced urticaria: A dominantly inherited disorder, J. Allergy Clin. Immunol. 59: 294–297.
Spaulding, W. B., 1960, Methyl testosterone therapy for hereditary episodic edema (hereditary angioneurotic edema), Ann. Intern. Med. 53: 739–745.
Swinny, B., 1941, The atopic factor in urticaria, South. Med. J. 34: 855–858.
Szczeklik, A., Oryglewski, R. J., and Czerniawska-Mysik, 1975, Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients, Br. Med. J. 1: 67.
Talamo, R. C., Haber, E., and Austen, K. F., 1969, A radioimmunoassay for bradykinin in plasma and synovial fluid, J. Lab. Clin. Med. 74: 816–827.
Thompson, R. A., 1972, C3 inactivating factor in the serum of a patient with chronic hypocomplementemia proliferative glomerulonephritis, Immunology 22: 147–158.
Thompson, R. A., and Lachmann, P. J., 1977, A second case of human C3b inhibitor (KAF) deficiency, Clin. Exp. Immunol. 27: 23–29.
Thompson, R. E., Mandle, R. J., Jr., and Kaplan, A. P., 1977, Association of factor XI and high molecular weight kininogen in human plasma, J. Clin. Invest. 60: 1376–1480.
Tindall, J. P., Beeker, S. K., and Rosse, N. F., 1969, Familial cold urticaria, Arch. Intern. Med. 124: 129–134.
Tomioka, H., and Ishizaka, K., 1971, Mechanisms of passive sensitization. II. Presence of receptors for IgE in monkey mast cells, J. Immunol. 107: 971–978.
Tromovitch, T. A., 1967, Urticaria from contact with water, Calif. Med. 106: 400–401.
Unger, A. H., 1960, Chronic urticaria. II. Association with dental infections, South. Med. J. 53: 178–181.
Vallota, E. H., and Müller-Eberhard, H. J., 1973, Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivatior, J. Exp. Med. 137: 1109–1123.
Vallota, E. H., Gotze, O. Spiegelberg, H. L., Forristal, J., West, C. D., and Müller-Eberhard, H. J., 1974, A serum factor in chronic hypocomplementemic nephritis distinct from immunoglobulins and activating the alternative pathway of complement, J. Exp. Med. 139: 1249–1261.
Vane, J. R., 1971, Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs, Nature (London) New Biol. 231: 232–235.
Waldbott, G. L., and Merkle, K., 1952, Urticaria due to pollen, Ann. Allergy 10: 30–35.
Wanderer, A. A., and Ellis, E. F., 1971, Treatment of cold urticaria with cyproheptadine, J. Allergy Clin. Immunol. 48: 366–371.
Wanderer, A. A., Maselli, R., Ellis, R. F., and Ishizaka, K., 1971, Immunologic characterization of serum factors responsible for cold urticaria, J. Allergy Clin. Immunol. 48: 13–22.
Warin, R. P., and Champion, R. H., 1974, Urticaria, p. 33, Saunders, London.
Wasserman, S. I., Soter, N. A., Center, D. M., and Austen, K. F., 1977, Cold urticaria: Recognition and characterization of a neutrophil chemotactic factor which appears in serum duing experimental cold challenge, J. Clin. Invest. 60; 189–196.
Webb, D. R., Pearsall, H. R., and Sumida, S. E., 1975, Depression of third component of complement (C3) in chronic angioedema, J. Allergy Clin. Immunol. 55: 106 (abstr.).
Weiss, A. S., Gallin, J. I., and Kaplan, A. P., 1973, Fletcher factor deficiency: Abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation attributable to absence of prekallikrein, J. Clin. Invest. 53: 622–633.
Willms, K., Rosen, F. S., and Donaldson, V. H., 1975, Observations in the ultrastructure of lesions induced in human and guinea pig skin by Cl esterase and polypeptide from hereditary angioneurotic edema (HANE) plasma, Clin. Immunol. Immunopathol. 4: 174–188.
Wilner, G. D., Nossel, H. L., and Leroy, E. C., 1968, Activation of Hageman factor by collagen, J. Clin. Invest. 47: 2608–2615.
Wuepper, K. D., 1973, Prekallikrein deficiency in man, J. Exp. Med. 138: 1345–1355.
Wuepper, K. D., Bokisch, V. A., Müller-Eberhard, H. J., and Stoughton, R. B., 1972, Cutaneous responses to human C3a anaphylatoxin in man, Clin. Exp. Immunol. 11: 13–20.
Wuepper, K. D., Miller, D. R., and LaCombe, M. J., 1975, Flaujeac trait: Deficiency of human plasma kininogen, J. Clin. Invest. 56: 2663–1672.
Yurchak, A. M., Wicher, K., and Arbesman, C. E., 1970, Immunologic studies on aspirin, J. Allergy 46: 245–253.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1979 Plenum Publishing Corporation
About this chapter
Cite this chapter
Kaplan, A.P. (1979). Urticaria and Angioedema. In: Gupta, S., Good, R.A. (eds) Cellular, Molecular, and Clinical Aspects of Allergic Disorders. Comprehensive Immunology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-0988-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0988-8_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-0990-1
Online ISBN: 978-1-4684-0988-8
eBook Packages: Springer Book Archive